AD/PD 2027 Advances in Science & Therapy

AD/PD™ focuses on basic science and translational and clinical research to bring you:

• Mechanisms: Neurodegeneration, protein aggregation, and the fundamental pathways of disease.
• Clinical Trials: Phase I–III trial presentation and the future of pharmacological intervention.
• Diagnostics: Fluid markers, neuroimaging, and the advancement of early detection.
• Drug Discovery: Translating chemical leads into viable therapeutic strategies.
• New Therapies: Gene therapy, immunotherapy, and regenerative medicine breakthroughs.
• Prevention: Lifestyle, risk factors, and the proactive shield against decline.